rs908644

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000540.3(RYR1):​c.10825-218C>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.179 in 632,186 control chromosomes in the GnomAD database, including 11,882 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). The gene RYR1 is included in the ClinGen Criteria Specification Registry.

Frequency

Genomes: 𝑓 0.22 ( 4233 hom., cov: 31)
Exomes 𝑓: 0.17 ( 7649 hom. )

Consequence

RYR1
NM_000540.3 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2O:1

Conservation

PhyloP100: -0.204

Publications

7 publications found
Variant links:
Genes affected
RYR1 (HGNC:10483): (ryanodine receptor 1) This gene encodes a ryanodine receptor found in skeletal muscle. The encoded protein functions as a calcium release channel in the sarcoplasmic reticulum but also serves to connect the sarcoplasmic reticulum and transverse tubule. Mutations in this gene are associated with malignant hyperthermia susceptibility, central core disease, and minicore myopathy with external ophthalmoplegia. Alternatively spliced transcripts encoding different isoforms have been described. [provided by RefSeq, Jul 2008]
RYR1 Gene-Disease associations (from GenCC):
  • malignant hyperthermia, susceptibility to, 1
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), PanelApp Australia, Genomics England PanelApp, Ambry Genetics, ClinGen
  • RYR1-related myopathy
    Inheritance: AD, AR Classification: DEFINITIVE, STRONG Submitted by: ClinGen, PanelApp Australia
  • congenital multicore myopathy with external ophthalmoplegia
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Genomics England PanelApp
  • central core myopathy
    Inheritance: AD, AR Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), Genomics England PanelApp
  • King-Denborough syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • malignant hyperthermia of anesthesia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • autosomal recessive centronuclear myopathy
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • benign Samaritan congenital myopathy
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • congenital myopathy with myasthenic-like onset
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • lethal multiple pterygium syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.97).
BP6
Variant 19-38528088-C-G is Benign according to our data. Variant chr19-38528088-C-G is described in ClinVar as Benign. ClinVar VariationId is 133000.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.356 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000540.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
RYR1
NM_000540.3
MANE Select
c.10825-218C>G
intron
N/ANP_000531.2P21817-1
RYR1
NM_001042723.2
c.10810-218C>G
intron
N/ANP_001036188.1P21817-2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
RYR1
ENST00000359596.8
TSL:5 MANE Select
c.10825-218C>G
intron
N/AENSP00000352608.2P21817-1
RYR1
ENST00000355481.8
TSL:1
c.10810-218C>G
intron
N/AENSP00000347667.3P21817-2
RYR1
ENST00000594335.6
TSL:1
n.*1553-218C>G
intron
N/AENSP00000470927.2M0R014

Frequencies

GnomAD3 genomes
AF:
0.216
AC:
32756
AN:
151604
Hom.:
4215
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.360
Gnomad AMI
AF:
0.249
Gnomad AMR
AF:
0.182
Gnomad ASJ
AF:
0.178
Gnomad EAS
AF:
0.176
Gnomad SAS
AF:
0.284
Gnomad FIN
AF:
0.162
Gnomad MID
AF:
0.199
Gnomad NFE
AF:
0.145
Gnomad OTH
AF:
0.211
GnomAD2 exomes
AF:
0.185
AC:
13159
AN:
71204
AF XY:
0.183
show subpopulations
Gnomad AFR exome
AF:
0.372
Gnomad AMR exome
AF:
0.142
Gnomad ASJ exome
AF:
0.177
Gnomad EAS exome
AF:
0.164
Gnomad FIN exome
AF:
0.155
Gnomad NFE exome
AF:
0.142
Gnomad OTH exome
AF:
0.184
GnomAD4 exome
AF:
0.168
AC:
80532
AN:
480464
Hom.:
7649
Cov.:
5
AF XY:
0.172
AC XY:
43965
AN XY:
255524
show subpopulations
African (AFR)
AF:
0.372
AC:
4987
AN:
13416
American (AMR)
AF:
0.148
AC:
3498
AN:
23700
Ashkenazi Jewish (ASJ)
AF:
0.180
AC:
2674
AN:
14836
East Asian (EAS)
AF:
0.148
AC:
4667
AN:
31428
South Asian (SAS)
AF:
0.269
AC:
13237
AN:
49258
European-Finnish (FIN)
AF:
0.164
AC:
4895
AN:
29928
Middle Eastern (MID)
AF:
0.208
AC:
439
AN:
2114
European-Non Finnish (NFE)
AF:
0.143
AC:
41320
AN:
288614
Other (OTH)
AF:
0.177
AC:
4815
AN:
27170
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
3959
7918
11876
15835
19794
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
380
760
1140
1520
1900
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.216
AC:
32824
AN:
151722
Hom.:
4233
Cov.:
31
AF XY:
0.220
AC XY:
16302
AN XY:
74178
show subpopulations
African (AFR)
AF:
0.360
AC:
14892
AN:
41310
American (AMR)
AF:
0.181
AC:
2764
AN:
15246
Ashkenazi Jewish (ASJ)
AF:
0.178
AC:
618
AN:
3470
East Asian (EAS)
AF:
0.175
AC:
902
AN:
5142
South Asian (SAS)
AF:
0.284
AC:
1364
AN:
4806
European-Finnish (FIN)
AF:
0.162
AC:
1705
AN:
10552
Middle Eastern (MID)
AF:
0.194
AC:
57
AN:
294
European-Non Finnish (NFE)
AF:
0.145
AC:
9843
AN:
67888
Other (OTH)
AF:
0.215
AC:
452
AN:
2102
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1222
2444
3665
4887
6109
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
336
672
1008
1344
1680
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.178
Hom.:
388
Bravo
AF:
0.220
Asia WGS
AF:
0.286
AC:
995
AN:
3478

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
2
not provided (3)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.97
CADD
Benign
1.7
DANN
Benign
0.60
PhyloP100
-0.20
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs908644; hg19: chr19-39018728; COSMIC: COSV107443157; COSMIC: COSV107443157; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.